NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Wang Z, Pianosi P, Keogh K, et al. The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Dec. (Comparative Effectiveness Reviews, No. 197.)
The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management [Internet].
Show detailsThe Agency for Healthcare Research and Quality (AHRQ), through its Evidence-based Practice Centers (EPCs), sponsors the development of systematic reviews to assist public- and private-sector organizations in their efforts to improve the quality of health care in the United States. These reviews provide comprehensive, science-based information on common, costly medical conditions, and new health care technologies and strategies.
Systematic reviews are the building blocks underlying evidence-based practice; they focus attention on the strength and limits of evidence from research studies about the effectiveness and safety of a clinical intervention. In the context of developing recommendations for practice, systematic reviews can help clarify whether assertions about the value of the intervention are based on strong evidence from clinical studies. For more information about AHRQ EPC systematic reviews, see www.effectivehealthcare.ahrq.gov/reference/purpose.cfm
AHRQ expects that these systematic reviews will be helpful to health plans, providers, purchasers, government programs, and the health care system as a whole. Transparency and stakeholder input are essential to the Effective Health Care Program. Please visit the Web site (www.effectivehealthcare.ahrq.gov) to see draft research questions and reports or to join an e-mail list to learn about new program products and opportunities for input.
If you have comments on this systematic review, they may be sent by mail to the Task Order Officer named below at: Agency for Healthcare Research and Quality, 5600 Fisher Lane, Rockville, MD 20857, or by email to vog.shh.qrha@cpe.
- Gopal Khanna, M.B.A.DirectorAgency for Healthcare Research and Quality
- Stephanie Chang, M.D., M.P.H.DirectorEvidence-based Practice Center ProgramCenter for Evidence and Practice ImprovementAgency for Healthcare Research and Quality
- Arlene Bierman, M.D., M.S.Director Center for Evidence and Practice ImprovementAgency for Healthcare Research and Quality
- Aysegul Gozu, M.D., M.P.H.Task Order OfficerCenter for Evidence and Practice ImprovementAgency for Healthcare Research and Quality
- David W. Niebuhr, M.D., M.P.H., M.Sc.Task Order OfficerCenter for Evidence and Practice ImprovementAgency for Healthcare Research and Quality
- Preface - The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asth...Preface - The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management
- Key Informants - Pharmacokinetic/Pharmacodynamic Measures for Guiding Antibiotic...Key Informants - Pharmacokinetic/Pharmacodynamic Measures for Guiding Antibiotic Treatment for Hospital-Acquired Pneumonia
- Nuclear hormone receptor family member nhr-47 [Caenorhabditis elegans]Nuclear hormone receptor family member nhr-47 [Caenorhabditis elegans]gi|17562738|ref|NP_504455.1|Protein
- Key Informants - PCA3 Testing for the Diagnosis and Management of Prostate Cance...Key Informants - PCA3 Testing for the Diagnosis and Management of Prostate Cancer
- Trichosporon ovoides strain V26 internal transcribed spacer 1, partial sequence;...Trichosporon ovoides strain V26 internal transcribed spacer 1, partial sequence; 5.8S ribosomal RNA gene, complete sequence; and internal transcribed spacer 2, partial sequencegi|1005506896|gb|KT900115.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...